Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
In the highly competitive, new drug development market, biopharma companies face a myriad of challenges—from balancing cost, time, and quality, to delivering the best possible outcome for their trial and their patients. As biopharma companies move toward an Investigational New Drug (IND) application and their first human trial, many of them find themselves lacking the experience and knowledge in securing a reliable clinical supply chain strategy. A reliable clinical supply chain strategy is as essential as a company’s discovery program—making finding a partner who can help guide a comprehensive supply chain strategy and manage day-to-day supply chain activities, paramount.